ABOUT RESPIRATORY SYNCYTIAL VIRUS (RSV)

Respiratory syncytial virus (RSV), which causes infection of the lungs and breathing passages, is a major cause of respiratory illness, especially in young children. 

RESPIRATORY SYNCYTIAL VIRUS AND CHILD PNEUMONIA WEBINAR

Listen to talks by:
  • Dr. Ting Shi (University of Edinburgh): Global disease burden estimate of RSV in young children
  • Dr. Marijke Proesmans (Katholieke Universiteit Leuven): RSV therapeutics
  • Dr. Keith Klugman (Director, Pneumonia, Bill&Melinda Gates Foundation): RSV immunization and future directions
  • Dr. Louis Bont (Chairman ReSViNET Foundation): RSV clinical presentation and disease severity​
Use the link below to access the SlideShare presentation for the talks:
https://www.slideshare.net/secret/H0MzMgF2seNUX7
NOTE: Please download this slide deck from the SlideShare platform to view.

RSV GOLD

​RSV GOLD is an online accessible database containing information on individual RSV-related mortality cases. Health care providers and researchers from all over the world are encouraged to share cases of children dying from RSV infection.

​These confidential and anonymous data will be used to understand clinical and socio-economic characteristics of children dying from RSV infection and to determine the worldwide age distribution of these children.

Click the link below to go to the RSV GOLD database website.

RESVINET APP

Download here RESVINET scale App for pediatric respiratory assessment. Click here to read more
​

RESEARCH

We are open to collaborate in any RSV related research activity varying from advice to the necessary multidisciplinary engagements and clinical networks eventually necessary to develop the project.

We are very interested to collaborate in designing and performing clinical trials on RSV therapeutics that are aimed at decreasing the RSV burden/decreasing disease severity and saving young lives especially in developing countries.

Please contact us for possibilities.